HighPoint Advisor Group LLC Takes $1.12 Million Position in Axon Enterprise, Inc. (NASDAQ:AXON)

HighPoint Advisor Group LLC purchased a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXONFree Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 4,334 shares of the biotechnology company’s stock, valued at approximately $1,120,000.

Other hedge funds have also added to or reduced their stakes in the company. Norges Bank acquired a new position in shares of Axon Enterprise in the 4th quarter valued at approximately $195,406,000. Sands Capital Management LLC boosted its holdings in shares of Axon Enterprise by 31.1% in the 3rd quarter. Sands Capital Management LLC now owns 2,612,305 shares of the biotechnology company’s stock valued at $519,823,000 after purchasing an additional 619,179 shares in the last quarter. Westfield Capital Management Co. LP increased its stake in shares of Axon Enterprise by 184.3% in the 3rd quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock valued at $138,535,000 after purchasing an additional 451,350 shares during the last quarter. Polar Capital Holdings Plc raised its holdings in shares of Axon Enterprise by 292.0% during the 3rd quarter. Polar Capital Holdings Plc now owns 265,464 shares of the biotechnology company’s stock worth $52,825,000 after buying an additional 197,746 shares in the last quarter. Finally, International Assets Investment Management LLC acquired a new position in shares of Axon Enterprise during the 4th quarter worth $39,907,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Stock Up 0.6 %

NASDAQ:AXON traded up $1.66 on Tuesday, hitting $298.83. The stock had a trading volume of 29,377 shares, compared to its average volume of 486,823. The company has a market cap of $22.55 billion, a PE ratio of 86.89 and a beta of 0.91. Axon Enterprise, Inc. has a 52 week low of $175.37 and a 52 week high of $329.87. The business’s fifty day moving average is $297.59 and its 200 day moving average is $281.67. The company has a quick ratio of 2.55, a current ratio of 2.91 and a debt-to-equity ratio of 0.37.

Axon Enterprise (NASDAQ:AXONGet Free Report) last issued its quarterly earnings data on Friday, May 10th. The biotechnology company reported $1.15 EPS for the quarter, topping the consensus estimate of $0.95 by $0.20. The firm had revenue of $460.74 million during the quarter, compared to the consensus estimate of $441.57 million. Axon Enterprise had a return on equity of 11.71% and a net margin of 15.60%. The company’s quarterly revenue was up 34.3% compared to the same quarter last year. During the same period in the prior year, the business posted $0.51 earnings per share. On average, equities research analysts expect that Axon Enterprise, Inc. will post 2.35 EPS for the current fiscal year.

Insider Transactions at Axon Enterprise

In other news, Director Jeri Williams sold 308 shares of the stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $310.07, for a total value of $95,501.56. Following the completion of the sale, the director now directly owns 1,607 shares of the company’s stock, valued at $498,282.49. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, Director Jeri Williams sold 308 shares of the stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $310.07, for a total transaction of $95,501.56. Following the completion of the sale, the director now directly owns 1,607 shares of the company’s stock, valued at $498,282.49. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, President Joshua Isner sold 44,000 shares of the stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $309.96, for a total value of $13,638,240.00. Following the sale, the president now directly owns 275,843 shares of the company’s stock, valued at $85,500,296.28. The disclosure for this sale can be found here. Insiders sold a total of 89,447 shares of company stock valued at $27,684,677 over the last ninety days. 5.70% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of equities analysts have recently commented on the company. JMP Securities reissued a “market outperform” rating and set a $375.00 price target on shares of Axon Enterprise in a report on Tuesday, May 7th. Craig Hallum upped their target price on Axon Enterprise from $325.00 to $370.00 and gave the stock a “buy” rating in a report on Tuesday, May 7th. Robert W. Baird upped their target price on Axon Enterprise from $260.00 to $300.00 and gave the stock an “outperform” rating in a report on Thursday, February 22nd. TheStreet cut Axon Enterprise from a “b” rating to a “c+” rating in a report on Tuesday, February 27th. Finally, Barclays upped their target price on Axon Enterprise from $308.00 to $381.00 and gave the stock an “overweight” rating in a report on Wednesday, May 8th. Two equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus price target of $335.27.

Get Our Latest Report on Axon Enterprise

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Stories

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.